Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/FCF ratio is N/A as of 2026-10-06T12:50:42.529Z.
Calculation as of: 2026-10-06T12:50:42.529Z.
Quote observation: 2026-10-05T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: d0d16669f7a2c0e1646e6313a61118319ccaec2b3022f40527d46d929c834448
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/FCF RATIO
N/A
Market Cap
$244.25M
Price/FCF Ratio
6.08
TTM Avg
7.87
3Y Avg
7.87
5Y Avg
7.87
Market Cap
$245.65M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$248.21M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$251.64M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | PRICE/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioAge Labs Inc. (BIOA) | $239.45M | N/A | N/A | N/A | N/A |
| High Tide Inc. (HITI)vs › | $239.89M | 20.91 | 18.26 | 16.59 | 17.78 |
| Biodesix, Inc. (BDSX)vs › | $236.56M | N/A | N/A | N/A | N/A |
| Akebia Therapeutics, Inc. (AKBA)vs › | $244.25M | 6.08 | 7.87 | 7.87 | 7.87 |
| Galectin Therapeutics Inc. (GALT)vs › | $245.65M | N/A | N/A | N/A | N/A |
| InflaRx N.V. (IFRX)vs › | $247.45M | N/A | N/A | N/A | N/A |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $248.21M | N/A | N/A | N/A | N/A |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $251.64M | N/A | N/A | N/A | N/A |
| Alector, Inc. (ALEC)vs › | $220.94M | N/A | 3.22 | 3.23 | 4.48 |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $259.30M | N/A | N/A | N/A | N/A |
P/FCF Ratio
N/A
FCF Yield
N/A
P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
